Lecanemab Phase 3 Clarity Core Study Primary Completion

598
days
23
hours
32
minutes
6
seconds
Time since Thursday, September 15, 2022 at 7:30:00 pm (Tokyo time)

NOTE: Message provided by user. Create your own countdown

Related Links